A reply: Wrong drug problem continues

A Problem in Avicennas View on the Origination of the Soul and a Reply to It

Drug safety and salmeterol: the controversy continues.

Since their introduction in the 1960s, inhaled -agonists have been celebrated for their ability to offer dramatic relief of symptoms for persons with asthma. However, they have engendered considerable controversy. Early indications suggested that higher doses of some of the shortacting -agonists were associated with higher fatal and near-fatal asthma-related events (1). Further research suggest...

Adverse events in anaesthesia: the wrong drug.

The first general anaesthetics resulted from the action of one drug, either ether or chloroform. Today, general anaesthetics are usually complex "cocktails" and it is not uncommon for several different drugs to be given. Each of these has a distinct, predictable pharmacological action. Thus, when an unpredicted reaction occurs shortly after the injection of a drug, one possible explanation is t...

a problem in avicennas view on the origination of the soul and a reply to it

0

Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?

I nterest in and controversy over the use of bevacizumab (Avastin; Genentech/Roche, South San Francisco, CA) for the treatment of retinopathy of prematurity (ROP) have increased dramatically after the Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity (BEAT-ROP) study. Off-label bevacizumab has been used extensively for age-related macular degeneration (AMD) for more tha...